MediPharm Labs (TSE:LABS) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
MediPharm Labs is selling its Napanee facility to Kensana Health for $5.5 million, forming a strategic partnership to enhance their manufacturing capabilities and support future growth. This move aligns with MediPharm’s strategy to streamline operations and maximize stakeholder value, while Kensana aims to advance its phytopharmaceutical development. The deal is expected to close by January 1, 2025.
For further insights into TSE:LABS stock, check out TipRanks’ Stock Analysis page.